Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744328 · ClinicalTrials.gov registry record · Phase 4
Postpartum Depression: Transdermal Estradiol Versus Sertraline
A Phase 4 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 85
- Enrollment target
NCT00744328 is a Phase 4 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 85 participants.
The verdict
NCT00744328, a Phase 4 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether estrogen patches are effective for the treatment of postpartum major depression, as compared to sertraline (Zoloft) and placebo.
Interventions
- OTHER Placebo
- DRUG Sertraline
- DRUG Transdermal Estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744328
The ClinicalTrials.gov registry entry for NCT00744328 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00744328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00744328 about?
NCT00744328 is a clinical study titled "Postpartum Depression: Transdermal Estradiol Versus Sertraline". The purpose of this study is to determine whether estrogen patches are effective for the treatment of postpartum major depression, as compared to sertraline (Zoloft) and placebo.
What is the current status of trial NCT00744328?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 85 participants. The study started on 2008-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00744328?
The interventions under investigation include: Placebo (OTHER), Sertraline (DRUG), Transdermal Estradiol (DRUG).
Who is sponsoring clinical trial NCT00744328?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.